GlassScriptPhysician profile
Ali Mohammad Sobh
NPI 1558993659
$14,751.26
in general payments reported to CMS, 2019-2025
15 companies · $2,997 in 2025
The $2,997 reported for 2025 was more than what 97% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,171 · 2022: $1,368 · 2023: $1,733 · 2024: $7,483 · 2025: $2,997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,036 · Travel and Lodging: $5,046 · Education: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,036.14 |
| Travel and Lodging | $5,046.47 |
| Education | $130.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $5,231.91 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Pascal |
| Medtronic, INC. | $4,642.86 | 2021-2025 | Corevalve Evolut R |
| Amgen INC. | $2,103.30 | 2021-2025 | Repatha, Repatha |
| Abbott Laboratories | $1,268.93 | 2022-2024 | Mitraclip, Jot Dx, Aveir |
| Boston Scientific Corporation | $566.39 | 2021-2025 | Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $229.78 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $158.27 | 2021-2025 | Farxiga |
| Atricure, INC. | $125.07 | 2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System, Atriclip Laa Exclusion System |
| W. L. Gore & Associates, INC. | $119.34 | 2022 | |
| Pfizer INC. | $76.96 | 2021-2022 | |
| Octapharma USA, INC. | $71.35 | 2025 | Fibryga |
| Philips North America LLC | $66.22 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.14 | 2024-2025 | Jardiance |
| Shockwave Medical, INC | $21.70 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lilly USA, LLC | $20.04 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Sobh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.